BioXcel Therapeutics (BTAI) Inventory (2022 - 2026)

BioXcel Therapeutics' Inventory history runs 5 years deep, the most recent figure standing at $500000.0 for Q1 2026.

• In Q1 2026, Inventory fell 22.12% year-over-year to $500000.0; the TTM figure through Mar 2026 stood at $500000.0 (down 22.12% YoY), while the FY2025 annual figure was $722000.0, up 6.33% from the prior year.
• Inventory was $500000.0 for Q1 2026 at BioXcel Therapeutics, down from $722000.0 in the prior quarter.
• In the past five years, Inventory ranged from a high of $2.7 million in Q2 2024 to a low of $459000.0 in Q3 2025.
• Historically, Inventory has averaged $1.4 million across 5 years, with a median of $1.4 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Inventory jumped 186.22% in 2023, then plunged 81.12% in 2025.
• A 5-year view of Inventory shows it stood at $2.0 million in 2022, then advanced by 0.3% to $2.0 million in 2023, then plunged by 65.9% to $679000.0 in 2024, then rose by 6.33% to $722000.0 in 2025, then tumbled by 30.75% to $500000.0 in 2026.
• The last three Inventory figures came in at $500000.0 (Q1 2026), $722000.0 (Q4 2025), and $459000.0 (Q3 2025), per Business Quant data.